HSV-2 Vaccine Study

Now Enrolling in Cleveland, Grand Island, and Norfolk

● Now Enrolling

About this research study

Herpes simplex virus (HSV) is a common infection that can cause painful blisters or ulcers. It primarily spreads by skin-to-skin contact. Symptoms of the virus can include painful, recurring blisters or ulcers. New infections may cause fever, body aches, and swollen lymph nodes while recurrent episodes may begin with tingling, itching, or burning where sores will appear. Herpes is treatable, but there is no cure.

Velocity is now seeking participants for an investigational mRNA genital herpes vaccine study.

Eligible participants...

Must be age 18 to 55
Must have a diagnosis of genital HSV-2 infection for at least 1 year
Must have a history of recurrent genital herpes of at least 3 and less than 10 reported recurrences in the past year
Will receive compensation for study-related time and travel

For more information, complete the form on this page. After you submit your information, a Velocity enrollment specialist will call you to talk about the study. There is no obligation to participate — you can decide if the study is right for you.

More information about participating in a clinical trial...

After you submit your information, a Velocity enrollment specialist will contact you.

Participating in a study is an important decision — we’re here to help you before, during, and after studies.

Please note: Health insurance is NOT required to join.

Is participation voluntary after I submit my information?

Yes. Participation in a study is entirely voluntary. In the informed consent process, you’ll learn about the product being studied, the participant’s role in the study, potential side effects, the number of visits that may be required, and more. Participants must sign an informed consent form to join the study.

Will I receive compensation?

While participation in a clinical study is voluntary, you may be paid for study-related time. After you submit your information, a Velocity enrollment specialist will call you to talk about the study. Staff at the research clinic will discuss possible payment with you.

Enter your info

Facebook

This field is for validation purposes and should be left unchanged.

Name(Required)

Phone(Required)

Date of birth(Required)

Age can help us determine study eligibility (you must be age 18 or older to submit this form).

Month

Day

Year

Location and study of interest(Required)

Gender

Preferred language

Are you Hispanic or Latino?(Required)

Race(Required)

Select one or more designations that best describe you. This information can help Velocity better ensure all populations are represented in research.

American Indian or Alaskan Native

Asian

Black or African American

Native Hawaiian or Other Pacific Islander

White or Caucasian

This field is hidden when viewing the form

MobileOptIn

By entering your email address and/or phone number on this form, you represent that you are at least 18 years of age and you consent to receiving telephone calls and/or emails from Velocity Clinical Research or a third party on behalf of Velocity Clinical Research. For any help regarding messaging, please email us at [email protected]. For full details, refer to Velocity's privacy policy and website terms of use. Submissions on this website are not monitored 24/7. Do NOT submit personal health or medical information on this form. If you are enrolled in a trial and have questions, please call your research site.

Study Locations

Cleveland, Ohio • Velocity Clinical Research

3619 Park East Dr., Suite 300, Beachwood, OH 44122
Phone: (216) 682-0320

Grand Island, Nebraska • Velocity Clinical Research

711 N. Custer Ave., Suite B, Grand Island, NE 68803
Phone: (308) 365-8900

Norfolk, Nebraska • Velocity Clinical Research

3400 W Norfolk Avenue, Norfolk, NE 68701
Phone: (402) 371-0797